81 related articles for article (PubMed ID: 9463005)
1. [The characteristics of the immune disorders in primary and repeated craniocerebral trauma].
Lisianyĭ MI; Rudenko VA; Hniedkova IO; Lisianyĭ OM; Horobets' OV
Fiziol Zh (1994); 1997; 43(5-6):3-10. PubMed ID: 9463005
[TBL] [Abstract][Full Text] [Related]
2. [The effect of experimental craniocerebral trauma on cell-mediated and humoral immunity reactions].
Ormantaev KS; Nadirov BN; Beliaev NN; Zakir'ianova GK; Tleulieva RT
Zh Vopr Neirokhir Im N N Burdenko; 1998; (4):27-9; discussion 29-30. PubMed ID: 9988889
[TBL] [Abstract][Full Text] [Related]
3. [A clinico-immunological study in recurrent mild craniocerebral trauma in the acute period].
Gorbunov VI
Zh Vopr Neirokhir Im N N Burdenko; 1999; (2):17-21. PubMed ID: 10420540
[TBL] [Abstract][Full Text] [Related]
4. [Free-radical and neuroimmune processes in primary and repeated craniocerebral trauma (in an experiment)].
Pedachenko EG; Sutkovoĭ DA; Lisianyĭ AN; Rudenko VA; Guk AP; Markina EA; Glushchenko NV; Fedosenko TN
Zh Vopr Neirokhir Im N N Burdenko; 1998; (4):24-7. PubMed ID: 9988888
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of the cellular immune response following closed head injury.
Czigner A; Mihály A; Farkas O; Büki A; Krisztin-Péva B; Dobó E; Barzó P
Acta Neurochir (Wien); 2007 Mar; 149(3):281-9. PubMed ID: 17288002
[TBL] [Abstract][Full Text] [Related]
6. [Correction of immunity disorder developing after craniocerebral trauma].
Romodanov AP; Lisianyĭ NI; Kurganova LV
Biull Eksp Biol Med; 1989 Aug; 108(8):231-3. PubMed ID: 2804331
[TBL] [Abstract][Full Text] [Related]
7. [Changes in the cellular immunity factors in suppurative complications of penetrating craniocerebral trauma].
Rodiukova EN; Kharitonova KI; Stupak IN; Stupak VV
Zh Vopr Neirokhir Im N N Burdenko; 1992; (2-3):12-5. PubMed ID: 1326192
[TBL] [Abstract][Full Text] [Related]
8. [The immunological aspects of the periodization of the course of craniocerebral trauma].
Gorbunov VI; Gannushkina IV
Zh Vopr Neirokhir Im N N Burdenko; 1990; (6):23-5. PubMed ID: 1963511
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of the T-system of immunity in patients with craniocerebral injuries].
Sokolova TF; Red'kin IuV; Goriachev AN; Sidorov VF
Zh Vopr Neirokhir Im N N Burdenko; 1984; (2):27-32. PubMed ID: 6234727
[TBL] [Abstract][Full Text] [Related]
10. [Immunological reactivity and nonspecific resistance in the early posttraumatic period in victims with closed craniocerebral trauma].
Starchenko AA; Khlunovskiĭ AN; Khil'ko VA; Komarets SA; Vlasenko IE; Paskhina MN; Lushnov MS
Vestn Khir Im I I Grek; 1994; 153(7-12):63-5. PubMed ID: 7625040
[TBL] [Abstract][Full Text] [Related]
11. [The immunological aspect of the processes of adaptation and compensation in the acute period of craniocerebral trauma].
Gorbunov VI
Zh Vopr Neirokhir Im N N Burdenko; 1992; (1):27-9. PubMed ID: 1316699
[TBL] [Abstract][Full Text] [Related]
12. Accelerated thymus involution in magnesium-deficient rats is related to enhanced apoptosis and sensitivity to oxidative stress.
Malpuech-Brugère C; Nowacki W; Gueux E; Kuryszko J; Rock E; Rayssiguier Y; Mazur A
Br J Nutr; 1999 May; 81(5):405-11. PubMed ID: 10615213
[TBL] [Abstract][Full Text] [Related]
13. [Immune status dynamics in different lateralizations of focal traumatic brain lesions].
Gorbunov VI; Gannushkina IV; Likhterman LB
Zh Vopr Neirokhir Im N N Burdenko; 1994; (3):13-6. PubMed ID: 7985436
[TBL] [Abstract][Full Text] [Related]
14. [The immunologic aspects of inflammatory complications in combined maxillofacial and craniocerebral trauma].
Zuev VP; Minkin LN; Timofeev VT
Stomatologiia (Mosk); 1989; 68(6):18-20. PubMed ID: 2623679
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
16. The effect of single and double trauma on the mitotic activity of bone marrow and thymus.
Johnell O; Hulth A
Acta Chir Scand; 1979; 145(2):73-5. PubMed ID: 313645
[TBL] [Abstract][Full Text] [Related]
17. [Immunogenetic indices in the acute period of a mild closed craniocerebral injury].
Kholodnyĭ AIa; Golovkin VI; Turbina IL; Ankhimova ES
Voen Med Zh; 1985 Oct; (10):54-5. PubMed ID: 3878034
[No Abstract] [Full Text] [Related]
18. [Immunomodulating action of myelopeptides in severe closed experimental craniocerebral injury in rats].
Lisianyĭ NI; Radzhievskiĭ AA; Zakharova LA
Biull Eksp Biol Med; 1988 Mar; 105(3):310-1. PubMed ID: 3349170
[TBL] [Abstract][Full Text] [Related]
19. [T- and B-lymphocytes, interleukins and natural killers in patients with osteomyelitis developing after combined injuries to the maxillofacial and craniocerebral areas].
Zuev VP; Grigor'iants LA; Litvinova LL; Eremeev VV; Rakhmetov BR
Stomatologiia (Mosk); 1991; 70(3):34-6. PubMed ID: 1926203
[TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
